Cancer therapy products are the top advertised drugs in professional health journals through Q3 2014
Print advertising dollars in professional health journals reached more than $443 million through September 2014, a 1% increase year-over-year, according to Kantar Media. The leading product class continues to be Cancer Therapy Products with more than $34 million spent in advertising in print medical journals. This product class makes up about 8% of the total market share through September.
The top product classes by dollars are as follows:
Top 5 Print Ad Drug Classes (Dollars): September 2014
#1 Cancer Therapy Products - $34 MM (-1%)
#2 Diabetes Oral - $14 MM (+28%)
#3 Anticoagulants Oral - $13 MM (-37%)
#4 Antivirals Other - $9 MM (+311%)
#5 Antidepressants - $9 MM (N/A)
The percentage changes compare September 2014 to that same time period in 2013. For more information on these ad insights or other data, let one of us know.
Kantar Media sets the standard for accurate, comprehensive competitive advertising intelligence in the professional healthcare arena. Check back next month for updated data on the top products, classes, companies and category movers year-to-date.